John Philip Mayer

Title: Innovations by John Philip Mayer

Introduction

John Philip Mayer is a notable inventor based in Boulder, CO (US). He has made significant contributions to the field of biotechnology, particularly in the treatment of Schwann and colon cells. With a total of 4 patents to his name, Mayer's work has the potential to impact medical treatments and therapies.

Latest Patents

Mayer's latest patents include a method for treating Schwann and colon cells in vitro. This method promotes the survival and proliferation of Schwann cells by culturing them in the presence of peptides derived from the EGF-like domain of proteins from the NDF/heregulin family. Additionally, colon epithelial cells can be stimulated to multiply and differentiate using the same peptides. Another significant patent is for the treatment of Schwann cells in vivo, which allows these cells to survive longer and proliferate by contacting them with the aforementioned peptides.

Career Highlights

Mayer is currently associated with Amgen Inc., a leading biotechnology company. His work at Amgen focuses on innovative solutions that address critical health challenges. His research has contributed to advancements in cellular therapies and regenerative medicine.

Collaborations

Mayer has collaborated with esteemed colleagues such as Hsieng Sen Lu and Shinichi Hara. These collaborations have fostered a productive environment for research and development, leading to groundbreaking discoveries in their field.

Conclusion

John Philip Mayer's contributions to biotechnology through his patents and collaborations highlight his role as an influential inventor. His innovative methods for treating Schwann and colon cells demonstrate the potential for significant advancements in medical science.